Oorsprong van het eerstegraads netwerk van Mary Lynch
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Panag Pharma, Inc.
 Panag Pharma, Inc. Pharmaceuticals: MajorHealth Technology Panag Pharma, Inc. engages in the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Its product Topical A, provides a new approach to the treatment of chronic pain and inflammation. The company was founded by Mary Lynch, Melanie Kelly, Christian Lehmann, and Orlando Hung and is headquartered in Halifax, Canada.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mary Lynch via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| TETRA BIO-PHARMA INC. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
| Dalhousie University | College/University | Corporate Officer/Principal | |
| International Cannabinoid Research Society | Director/Board Member | ||
| The Canadian Consortium for the Investigation of Cannabinoids | Director/Board Member | ||
TALLC Corp., Inc.
 TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Pharmaceuticals: Major | Founder |
Statistieken
Internationaal
| Canada | 5 |
| Verenigde Staten | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Operationeel
| Corporate Officer/Principal | 4 |
| Founder | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Director/Board Member | 2 |
Sterkste connecties
| Insiders | |
|---|---|
| Melanie Kelly | 5 |
| Melanie Kelly | 2 |
| Christian Lehmann | 1 |
| Orlando Hung | 1 |
- Beurs
- Insiders
- Mary Lynch
- Bedrijfsconnecties
